Prana Thoracic Completes Series A Extension of $3 Million in Oversubscribed Round, Bringing Total Funding to $9 Million
Summary
HOUSTON, August 07, 2024--(BUSINESS WIRE)--Prana Thoracic, a Houston-based medtech startup, founded with a vision to transform lung cancer intervention, proudly announces the successful final closing of its Series A extension round. This marks a significant milestone in its journey to advance precision surgical solutions.Prana Thoracics Series A extension round was oversubscribed by 30%, highlighting strong investor confidence and interest in the companys innovative approach to lung cancer intervention. "Beyond lung applications, they are pioneering new methods to use this technology for other soft tissues and are actively exploring integration with ablation and robotic systems, aligning with the future direction of these fields. Our flagship product, the Prana System, has been meticulously designed to enable image-guided, minimally invasive surgery, conserving healthy tissue and driving personalized treatment plans in a range of conditions including lung cancer. Our team of leading surgeons, engineers, and entrepreneurs is obsessed with developing technologies that raise the bar for physicians and patients alike.Please follow us on X, LinkedIn, and Instagram.